Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the unresolved objections regarding terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 8690) (Text with EEA relevance)